Pharma: Other News To Note
Wednesday, April 17, 2013
CSL Behring, of King of Prussia, Pa., said European authorities approved an extended use of Berinert, a C1 esterase inhibitor concentrate, for pre-procedure prevention of acute episodes of hereditary angioedema in adult and pediatric patients undergoing medical, dental or surgical procedures.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.